BMJ Evidence-Based Medicine

Papers
(The TQCC of BMJ Evidence-Based Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Pharmacological interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units: a network meta-analysis64
Development of literature search strategies for evidence syntheses: pros and cons of incorporating text mining tools and objective approaches59
Attitudes of people living with cancer towards trial non-publication and research participation47
Caring without boundaries: delimiting shared decision-making47
The Pandora’s Box of Evidence Synthesis and the case for a living Evidence Synthesis Taxonomy44
Rapid Reviews Methods Series: Involving patient and public partners, healthcare providers and policymakers as knowledge users43
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies40
Do infographics ‘spin’ the findings of health and medical research?34
High-value care education can learn from the evidence-based medicine movement: moving beyond competencies and curricula to culture33
Enhancing clinical practice guidelines with STAR33
Transparency of COVID-19 vaccine trials: decisions without data31
Consistency between trials presented at conferences, their subsequent publications and press releases29
The paradox of using SDM for de-implementation of low-value care in the clinical encounter29
Meta-analysis of continuous outcomes: a user’s guide for analysis and interpretation28
Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses28
Advocating for evidence-informed decisions to make healthcare fit for each person24
Quality of reporting among systematic reviews underpinning the ESC/ACC guidelines on ventricular arrhythmias and sudden cardiac death23
Dear doctor, please know that you do not know until I have told you22
Correspondence on ‘The limits of shared decision making’ by Elwynet al: We call for a more nuanced approach20
Making an organisation for health technology assessment: lessons from India20
How to interpret studies using Mendelian randomisation19
Reliance on the highest-quality studies of Long Covid is appropriate and not evidence of bias18
Correspondence on “How methodological pitfalls have created widespread misunderstanding about long COVID” by Høeget al18
Digitally enabled decentralised research: opportunities to improve the efficiency of clinical trials and observational studies17
Efficacy of non-pharmacological interventions for primary dysmenorrhoea: a systematic review and Bayesian network meta-analysis17
Challenges to delivering evidence-based management for long COVID16
Emollients and smoking: a fire hazard that could be prevented to reduce future deaths16
Likelihood ratio interpretation of the relative risk15
Reducing the residue of retractions in evidence synthesis: ways to minimise inappropriate citation and use of retracted data13
Sharing study materials in health and medical research13
Theory and practice of Bayesian and frequentist frameworks for network meta-analysis12
Bad news: how the media reported on an observational study about cardiovascular outcomes of COVID-1912
Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis11
Overdiagnosis and Barrett’s oesophagus: a call for clarity11
Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis11
Diagnostic accuracy of dipsticks for urinary tract infections in acutely hospitalised patients: a prospective population-based observational cohort study11
Quantifying the time-varying association between objectively measured physical activity and mortality in US older adults over a 12-year follow-up period: the NHANES 2003–2006 study11
Proposed framework for unifying disease definitions in guideline development10
Therapeutic quality of exercise interventions for chronic low back pain: a meta-research study using i-CONTENT tool10
How to best convey continuous outcomes in patient decision aids9
Facilitating GRADE judgements about the inconsistency of effects using a novel visualisation approach9
Investigation into financial conflicts of interest and screening for atrial fibrillation in the UK: a cross-sectional study8
Rapid reviews methods series: guidance on rapid qualitative evidence synthesis8
Early experience with the FDA’s regulatory review of novel gene therapies8
Meet generative AI� your new shared decision-making assistant8
Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?8
Metro Mapping: development of an innovative methodology to co-design care paths to support shared decision making in oncology8
Knowledge user survey and Delphi process to inform development of a new risk of bias tool to assess systematic reviews with network meta-analysis (RoB NMA tool)8
Global considerations for informed consent with shared decision-making in the digital age8
Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane8
Introduction of allergenic food to infants and allergic and autoimmune conditions: a systematic review and meta-analysis8
Context matters! What is really tested in an RCT?7
Can the HEARTS initiative reduce the burden of cardiovascular disease?7
Patients’ participation in government-sponsored guidelines in Latin America: a cross-sectional study7
Ten resources for understanding bias in health research: EBM live workshop 20227
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps7
COP27 climate change conference: urgent action needed for Africa and the world7
Proposed triggers for retiring a living systematic review6
Measuring progress in institutionalising evidence-informed priority-setting in the Indian healthcare system: an application using the iProSE scale6
Peer reviewers’ conflicts of interest in biomedical research: scoping review6
Implementing hierarchical network meta-analysis incorporating exchangeable dose effects compared to standard hierarchical network meta-analysis6
In-person schooling is essential even during periods of high transmission of COVID-196
Associations between device-measured and self-reported physical activity and common mental disorders: Findings from a large-scale prospective cohort study6
Interpreting the results from the first randomised controlled trial of colonoscopy: does it save lives?6
Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension6
Rapid reviews methods series: assessing the appropriateness of conducting a rapid review6
Ethical implications of AI-driven bias assessment in medicine5
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review5
Correlation between chest CT and RT-PCR testing in India’s second COVID-19 wave: a retrospective cohort study5
Relationship between the conflicts of interest and the results of meta-analyses of homoeopathy trials5
Adherence to the Guideline for Reporting Evidence-based practice Educational interventions and Teaching (GREET) of studies on evidence-based healthcare e-learning: a cross-sectional study5
Combining and converting groups when extracting data for meta-analysis5
Making sustainable healthcare decisions: three turns towards sustainable guidelines5
Expanding the measurement of overdiagnosis in the context of disease precursors and risk factors5
Reporting of patient-reported outcomes in trials on alcohol use disorder: a meta-epidemiological study5
Later is not necessarily better: limitations of survival analysis in studies of long-term drug treatment of psychiatric conditions5
Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis5
0.13620805740356